investigating remyelination with apo-transferrin and triiodothyronine
Published 3 years ago • 136 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
2:38
extracellular vesicles as nanocarriers of apo-transferrin for cns delivery
-
3:33
remyelinating treatments under investigation in ms
-
13:14
ingel therapeutics
-
2:44
dr. steven sherman describes the activation of ret via translocation
-
11:19
the stem cell frontier: translating breakthrough therapies
-
29:35
an overview of immunopathogenetic mechanisms
-
1:10
tu2218, a tgfβ-ri and vegfr2 dual inhibitor, with pembrolizumab in solid tumors
-
3:21
rmti attendees discuss their experiences at the regenerative medicine training institute
-
13:19
progress report vi - endre-botond gagyi
-
1:04
mantra: milademetan vs trabectedin in metastatic dedifferentiated liposarcoma
-
1:13
larotrectinib in patients with trk fusion salivary gland tumours
-
3:04
the future of regenerative medicine: overcoming immunosuppression requirements
-
9:48
francis arena, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
5:24
'lots to look forward to' as reneuron gets go-ahead for phase iib stroke trial
-
38:03
an overview of immunopathogenetic mechanisms
-
40:51
reconciling the stem/progenitor and paracrine functions of mscs - donald phinney
-
14:49
usc discussion: stemi & lm bifurcation stenting – case 2
-
1:04
phase iii invictus trial evaluates ripretinib in advanced gist